M 515
Pill imprint M 515 has been identified as Mirtazapine 15 mg.
Mirtazapine is used in the treatment of depression; anxiety; insomnia; hot flashes; post traumatic stress disorder and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy.
Mirtazapine 15 mg is not subject to the Controlled Substances Act.
See also related documents.
Mirtazapine Images
- Imprint:
-
M 515
- Strength:
- 15 mg
- Color:
- Beige
- Size:
- 7.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide
croscarmellose sodium
FD&C Blue No. 2
FD&C Yellow No. 6
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
corn starch
sodium lauryl sulfate
titanium dioxide
triacetin
- Drug Class:
- Tetracyclic antidepressants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-3515
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0086 | UDL Laboratories Inc |
| 54569-5895 | A S Medication Solutions LLC (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Mirtazapine resources
- Mirtazapine (Wolters Kluwer)
- Mirtazapine Orally Disintegrating Tablets (Wolters Kluwer)
- mirtazapine (Cerner Multum)
- Remeron RD (Micromedex) - Includes Dosage Information
- mirtazapine (Micromedex) - Includes Dosage Information
- Mirtazapine (AHFS DI)
- Mirtazapine Orally Disintegrating Tablets (FDA)
- Mirtazapine Tablets (FDA)
- Remeron Tablets (FDA)
- Mirtazapine (Wolters Kluwer)
Search Again
